Ban, Ehsan
Kalogerakos, Paris-Dimitrios
Khosravi, Ramak
Ziganshin, Bulat A.
Ellauzi, Hesham
Ramachandra, Abhay B.
Zafar, Mohammad A.
Humphrey, Jay D.
Elefteriades, John A. http://orcid.org/0000-0001-6255-8139
Article History
Received: 30 November 2022
Accepted: 27 March 2023
First Online: 12 April 2023
Declarations
:
: Disclosures: Drs. Ban, Kalogerakos, Khosravi, Ziganshin, Ellauzi, Ramachandra, and Zafar have no disclosures. J.D. Humphrey: Member of the Scientific Advisory Board who also receives consulting fees from HeartFlow, Inc., a company using computational modeling to assess coronary artery disease. J.A. Elefteriades: Principal, CoolSpine. CoolSpine has no clinical products.
: Drs. Ban, Kalogerakos, Khosravi, Ziganshin, Ellauzi, Ramachandra, and Zafar have no disclosures. J.D. Humphrey: Member of the Scientific Advisory Board who also receives consulting fees from HeartFlow, Inc., a company using computational modeling to assess coronary artery disease. J.A. Elefteriades: Principal, CoolSpine. CoolSpine has no clinical products.
: This study was approved by the Yale University Human Investigation Committee.